Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.16
HSIC's Cash to Debt is ranked lower than
60% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.78 vs. HSIC: 0.16 )
HSIC' s 10-Year Cash to Debt Range
Min: 0.04   Max: No Debt
Current: 0.16

Equity to Asset 0.48
HSIC's Equity to Asset is ranked higher than
69% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.37 vs. HSIC: 0.48 )
HSIC' s 10-Year Equity to Asset Range
Min: 0.21   Max: 0.67
Current: 0.48

0.21
0.67
Interest Coverage 24.59
HSIC's Interest Coverage is ranked higher than
69% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 7.81 vs. HSIC: 24.59 )
HSIC' s 10-Year Interest Coverage Range
Min: 4.68   Max: 24.59
Current: 24.59

4.68
24.59
F-Score: 7
Z-Score: 4.84
M-Score: -2.57
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 7.08
HSIC's Operating margin (%) is ranked higher than
78% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.78 vs. HSIC: 7.08 )
HSIC' s 10-Year Operating margin (%) Range
Min: 3.14   Max: 7.27
Current: 7.08

3.14
7.27
Net-margin (%) 4.51
HSIC's Net-margin (%) is ranked higher than
74% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.80 vs. HSIC: 4.51 )
HSIC' s 10-Year Net-margin (%) Range
Min: -0.13   Max: 4.76
Current: 4.51

-0.13
4.76
ROE (%) 15.49
HSIC's ROE (%) is ranked higher than
87% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.25 vs. HSIC: 15.49 )
HSIC' s 10-Year ROE (%) Range
Min: -0.52   Max: 15.49
Current: 15.49

-0.52
15.49
ROA (%) 7.67
HSIC's ROA (%) is ranked higher than
85% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.39 vs. HSIC: 7.67 )
HSIC' s 10-Year ROA (%) Range
Min: -0.27   Max: 8.11
Current: 7.67

-0.27
8.11
ROC (Joel Greenblatt) (%) 48.15
HSIC's ROC (Joel Greenblatt) (%) is ranked higher than
79% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 34.71 vs. HSIC: 48.15 )
HSIC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 14.17   Max: 49.36
Current: 48.15

14.17
49.36
Revenue Growth (%) 10.60
HSIC's Revenue Growth (%) is ranked higher than
68% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.60 vs. HSIC: 10.60 )
HSIC' s 10-Year Revenue Growth (%) Range
Min: 4.5   Max: 34.8
Current: 10.6

4.5
34.8
EBITDA Growth (%) 11.10
HSIC's EBITDA Growth (%) is ranked higher than
63% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.10 vs. HSIC: 11.10 )
HSIC' s 10-Year EBITDA Growth (%) Range
Min: 8.3   Max: 89.5
Current: 11.1

8.3
89.5
EPS Growth (%) 12.20
HSIC's EPS Growth (%) is ranked higher than
70% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.60 vs. HSIC: 12.20 )
HSIC' s 10-Year EPS Growth (%) Range
Min: 6.1   Max: 69.3
Current: 12.2

6.1
69.3
» HSIC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2013

HSIC Guru Trades in Q2 2013

Caxton Associates 14,033 sh (New)
Steven Cohen 12,680 sh (New)
Ron Baron 458,816 sh (+0.48%)
Columbia Wanger 1,222,500 sh (unchged)
Robert Olstein 46,000 sh (unchged)
Ken Fisher 589,899 sh (-0.01%)
Mario Gabelli 229,601 sh (-0.56%)
John Keeley 16,030 sh (-4.75%)
Jeremy Grantham 68,100 sh (-5.28%)
Paul Tudor Jones 4,400 sh (-37.14%)
Chuck Royce 1,010 sh (-94.04%)
» More
Q3 2013

HSIC Guru Trades in Q3 2013

Chuck Royce 7,430 sh (+635.64%)
Paul Tudor Jones 7,500 sh (+70.45%)
Columbia Wanger 1,225,500 sh (+0.25%)
Ron Baron 459,545 sh (+0.16%)
John Keeley Sold Out
Caxton Associates Sold Out
Mario Gabelli 229,201 sh (-0.17%)
Ken Fisher 586,063 sh (-0.65%)
Jeremy Grantham 57,300 sh (-15.86%)
Robert Olstein 29,000 sh (-36.96%)
Steven Cohen 6,285 sh (-50.43%)
» More
Q4 2013

HSIC Guru Trades in Q4 2013

Jim Simons 13,500 sh (New)
Joel Greenblatt 5,498 sh (New)
Steven Cohen 17,723 sh (+181.99%)
Columbia Wanger 1,225,500 sh (unchged)
Chuck Royce 7,430 sh (unchged)
Robert Olstein Sold Out
Jeremy Grantham 57,200 sh (-0.17%)
Ron Baron 455,496 sh (-0.88%)
Mario Gabelli 226,701 sh (-1.09%)
Ken Fisher 542,293 sh (-7.47%)
Paul Tudor Jones 5,654 sh (-24.61%)
» More
Q1 2014

HSIC Guru Trades in Q1 2014

Joel Greenblatt 84,157 sh (+1430.68%)
Jeremy Grantham 158,951 sh (+177.89%)
Ken Fisher 544,914 sh (+0.48%)
Ron Baron 455,571 sh (+0.02%)
Jim Simons Sold Out
Mario Gabelli 218,901 sh (-3.44%)
Chuck Royce 6,630 sh (-10.77%)
Columbia Wanger 1,007,500 sh (-17.79%)
Paul Tudor Jones 4,300 sh (-23.95%)
Steven Cohen 1,681 sh (-90.52%)
» More
» Details

Insider Trades

Latest Guru Trades with HSIC

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-03-31 Add 1430.68%0.14%$110.21 - $120.17 $ 119.232%84157
Joel Greenblatt 2013-12-31 New Buy0.02%$102.98 - $115.22 $ 119.237%5498
John Keeley 2013-09-30 Sold Out 0.01%$96.81 - $107.16 $ 119.2315%0
Tweedy Browne 2013-03-31 Sold Out 0.56%$80.42 - $92.55 $ 119.2336%0
Joel Greenblatt 2013-03-31 Sold Out 0.02%$80.42 - $92.55 $ 119.2336%0
John Keeley 2013-03-31 Reduce -26.54%0.01%$80.42 - $92.55 $ 119.2336%16830
John Keeley 2012-12-31 Reduce -56.29%0.05%$73.75 - $82.23 $ 119.2352%22910
Joel Greenblatt 2012-09-30 New Buy0.02%$74.64 - $80.27 $ 119.2354%4014
Ron Baron 2011-09-30 Reduce -36.26%0.1%$59.76 - $74.91 $ 119.2380%454271
Tweedy Browne 2011-06-30 Reduce -28.82%0.27%$68.38 - $74.08 $ 119.2368%290144
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Henry Schein Inc

Weekly 52-Week Highs Highlight: IHG, HSIC, GGP, AAL
According to GuruFocus list of 52-week highs, InterContinental Hotels Group PLC, Henry Schein Inc., General Growth Properties Inc. and American Airlines Group Inc. have all reached their 52-week highs. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 23.40
HSIC's P/E(ttm) is ranked higher than
70% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 30.20 vs. HSIC: 23.40 )
HSIC' s 10-Year P/E(ttm) Range
Min: 12.03   Max: 35.43
Current: 23.4

12.03
35.43
P/B 3.60
HSIC's P/B is ranked higher than
57% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.36 vs. HSIC: 3.60 )
HSIC' s 10-Year P/B Range
Min: 1.57   Max: 3.66
Current: 3.6

1.57
3.66
P/S 1.07
HSIC's P/S is ranked higher than
64% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.68 vs. HSIC: 1.07 )
HSIC' s 10-Year P/S Range
Min: 0.48   Max: 1.1
Current: 1.07

0.48
1.1
PFCF 17.90
HSIC's PFCF is ranked higher than
84% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 38.56 vs. HSIC: 17.90 )
HSIC' s 10-Year PFCF Range
Min: 9.15   Max: 62.56
Current: 17.9

9.15
62.56
EV-to-EBIT 15.84
HSIC's EV-to-EBIT is ranked higher than
73% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.16 vs. HSIC: 15.84 )
HSIC' s 10-Year EV-to-EBIT Range
Min: 7.3   Max: 20.5
Current: 15.84

7.3
20.5
PEG 2.10
HSIC's PEG is ranked higher than
80% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.08 vs. HSIC: 2.10 )
HSIC' s 10-Year PEG Range
Min: 0.53   Max: 3.4
Current: 2.1

0.53
3.4
Shiller P/E 28.90
HSIC's Shiller P/E is ranked higher than
82% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 81.32 vs. HSIC: 28.90 )
HSIC' s 10-Year Shiller P/E Range
Min: 16.95   Max: 40.01
Current: 28.9

16.95
40.01
Current Ratio 1.78
HSIC's Current Ratio is ranked higher than
76% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.53 vs. HSIC: 1.78 )
HSIC' s 10-Year Current Ratio Range
Min: 1.73   Max: 2.98
Current: 1.78

1.73
2.98
Quick Ratio 1.01
HSIC's Quick Ratio is ranked higher than
62% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.01 vs. HSIC: 1.01 )
HSIC' s 10-Year Quick Ratio Range
Min: 0.99   Max: 2.1
Current: 1.01

0.99
2.1

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 23.80
HSIC's Price/Tangible Book is ranked higher than
55% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 7.98 vs. HSIC: 23.80 )
HSIC' s 10-Year Price/Tangible Book Range
Min: 2.37   Max: 23.97
Current: 23.8

2.37
23.97
Price/DCF (Projected) 1.30
HSIC's Price/DCF (Projected) is ranked higher than
82% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.63 vs. HSIC: 1.30 )
HSIC' s 10-Year Price/DCF (Projected) Range
Min: 0.76   Max: 22.69
Current: 1.3

0.76
22.69
Price/Median PS Value 1.30
HSIC's Price/Median PS Value is ranked higher than
64% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.29 vs. HSIC: 1.30 )
HSIC' s 10-Year Price/Median PS Value Range
Min: 0.29   Max: 1.53
Current: 1.3

0.29
1.53
Price/Peter Lynch Fair Value 2.10
HSIC's Price/Peter Lynch Fair Value is ranked higher than
80% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 9999.00 vs. HSIC: 2.10 )
HSIC' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.59   Max: 3.33
Current: 2.1

0.59
3.33
Price/Graham Number 4.70
HSIC's Price/Graham Number is ranked higher than
62% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.27 vs. HSIC: 4.70 )
HSIC' s 10-Year Price/Graham Number Range
Min: 1.1   Max: 43.52
Current: 4.7

1.1
43.52
Earnings Yield (Greenblatt) 6.30
HSIC's Earnings Yield (Greenblatt) is ranked higher than
70% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.10 vs. HSIC: 6.30 )
HSIC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 4.9   Max: 13.6
Current: 6.3

4.9
13.6
Forward Rate of Return (Yacktman) 14.16
HSIC's Forward Rate of Return (Yacktman) is ranked higher than
67% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.14 vs. HSIC: 14.16 )
HSIC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 9.5   Max: 27.4
Current: 14.16

9.5
27.4

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:ABC, MCK, CAH, SHTDF, PDCO » details
Traded in other countries:HS2.Germany
Henry Schein, Inc. is incorporated in Delaware. It is a distributor of healthcare products and services primarily to office-based healthcare practitioners. It serves customers which include dental practitioners and laboratories, physician practices and animal health clinics, as well as government and other institutions. The Company conducts its business through two reportable segments namely healthcare distribution and technology and value-added services. The healthcare distribution reportable segment aggregates its dental, medical and animal health operating segments. This segment consists of consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The Company's technology and value-added services group provides software, technology and other value-added services to healthcare practitioners. It also offers practice management software systems for dental and medical practitioners and animal health clinics. The technology group offerings also include financial services on a non-recourse basis, e-services and continuing education services for practitioners. The Company has operations in the United States, Australia, Austria, Belgium, Canada, China, the Czech Republic, France, Germany, Hong Kong SAR, Iceland, Ireland, Israel, Italy, Luxembourg, Mauritius, the Netherlands, New Zealand, Portugal, Slovakia, Spain, Switzerland, Thailand, Turkey and the United Kingdom. The Company's competitors for dental products are Patterson Dental division of Patterson Companies, Inc. and Benco Dental Supply Company; for medical products are McKesson Corp., PSS World Medical, Inc. and Cardinal Health, Inc.; for animal health market are MWI Veterinary Supply Inc. and the Webster Veterinary division of Patterson Companies, Inc.; for dental practice management software are Carestream Health, Inc. and the Patterson Dental division of Patterson Companies, Inc. The Company markets its product directly through field sales consultants, direct marketing and telesales. The Company's business is subject to local, state, federal and foreign governmental laws and regulations applicable to the distribution of pharmaceuticals and medical devices.
» More Articles for HSIC

Headlines

Articles On GuruFocus.com
Weekly 52-Week Highs Highlight: IHG, HSIC, GGP, AAL Jun 02 2014 
Mario Gabelli on Aging America, Alcohol, Twitter, Facebook Dec 17 2013 
Importance of Leadership in a 5-Star Company Feb 05 2013 
Comment for Buffett-Munger Screener - Good Companies at Fair or Undervalued Prices -- GuruFocus.com Oct 12 2012 
Looking at the Big Picture Apr 25 2012 
Henry Schein Inc. (HSIC) President, COO James P Breslawski sells 46,000 Shares Mar 07 2011 
Henry Schein Inc. (HSIC) EVP, CFO Steven Paladino sells 26,000 Shares Feb 25 2011 
Henry Schein Inc. (HSIC) Chairman, CEO Stanley M Bergman sells 100,000 Shares May 14 2010 
Henry Schein Inc. (HSIC) EVP, CFO Steven Paladino sells 52,000 Shares May 12 2010 
The Enormous Mistake Public Pension Funds Are Making — and How You Can Avoid It Mar 25 2010 


More From Other Websites
Henry Schein To Webcast Second Quarter 2014 Conference Call On Monday, August 4, 2014 At 10:00 a.m.... Jul 21 2014
Henry Schein To Webcast Second Quarter 2014 Conference Call On Monday, August 4, 2014 At 10:00 a.m.... Jul 21 2014
Henry Schein Animal Health Completes Acquisition of Majority Interest in Equine Products Company... Jul 04 2014
Henry Schein Animal Health Completes Acquisition Of Majority Interest In Equine Products Company... Jul 01 2014
Henry Schein Animal Health Completes Acquisition Of Majority Interest In Equine Products Company... Jul 01 2014
Sirona Dental Hits New 52-Week High Jun 27 2014
Henry Schein Animal Health To Host 2014 Veterinary Technology Summit, September 3-5, In Chicago Jun 26 2014
Henry Schein Joins Dental Industry Leaders From Around The World To Unveil Tree Of Peace Statue At... Jun 18 2014
Henry Schein: Updated Research Report Jun 12 2014
Henry Schein 2014 Business Of Dentistry Conference Kicks Off August 7 Jun 11 2014
Henry Schein Acquires Sirona Direct Jun 04 2014
Henry Schein Elects Dr. E. Dianne Rekow To Board Of Directors Jun 03 2014
Henry Schein Acquires Sirona Direct Distribution Business In Paris Region, Expands Exclusive... Jun 03 2014
Henry Schein Climbs to #292 on the FORTUNE 500® Jun 02 2014
[$$] Ivy Mid Cap Growth: Rethinking Risk May 30 2014
Henry Schein Bites Into Brazil's Dental Market With Joint Venture May 30 2014
HENRY SCHEIN INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 29 2014
Henry Schein Takes Dental Biz to Brazil May 29 2014
Henry Schein acquires 50% ownership in Brazil's Dental Speed Graph May 28 2014
Henry Schein Enters Brazilian Dental Market with Investment in Dental Speed Graph May 28 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide